AFFINITY ASSET ADVISORS, LLC
Adviser information for AFFINITY ASSET ADVISORS, LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 8 |
---|---|
Investment Advisory/Research | 6 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 2 | $553.1M |
Non-Discretionary | 0 | $0 |
Total | 2 | $553.1M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 2 | $553.1M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 50 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
767 THIRD AVE15TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:30AM - 6PM
Tel: 646-481-3856, Fax: None
Chief Compliance Officer
JONATHAN CHU
CO-FOUNDER
767 THIRD AVE
15TH FLOOR
NEW YORK
NY
United States
Tel:
(646) 481-3856
C*********@**************M
(Full email address available in API data)
Regulatory Contact
MICHAEL CHO
CO-FOUNDER AND PORTFOLIO MANAGER
767 THIRD AVE
15TH FLOOR
NEW YORK
NY
United States
Tel:
(646) 481-3856
C*********@**************M
(Full email address available in API data)
Industry Affiliates
AFFINITY HEALTHCARE GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
AFFINITY HEALTHCARE FUND, LP | Hedge Fund | $553.1M | $1.0M | 95 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
CHO, MICHAEL | Individual | – | CO-FOUNDER, MANAGING PARTNER AND PORTFOLIO MANAGER | MANAGING MEMBER | 01/2017 | 50-75% |
CHU, JONATHAN, BO-SHING | Individual | – | CO-FOUNDER AND CHIEF COMPLIANCE OFFICER | MEMBER | 01/2017 | 10-25% |
NOSKER, PATRICK, LEONARD | Individual | – | DIRECTOR OF RESEARCH | MEMBER | 01/2021 | 10-25% |
HELLER, DANIEL, BARRY | Individual | – | CHIEF INVESTMENT OFFICER | MEMBER | 01/2021 | 10-25% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ADC THERAPEUTICS SA | SHS | 2M | 475K | – |
AEROVATE THERAPEUTICS INC | COM | 332K | 200K | – |
ALKERMES PLC | SHS | 16M | 650K | – |
ALNYLAM PHARMACEUTICALS INC | NOTE 1.000% 9/1 | 16M | – | – |
ALX ONCOLOGY HLDGS INC | COM | 603K | 100K | – |
APOGEE THERAPEUTICS INC | COM | 33M | 836K | – |
ARCA BIOPHARMA INC | COM | 278K | 72K | – |
ARCELLX INC | COMMON STOCK | 25M | 460K | – |
ARROWHEAD PHARMACEUTICALS IN | COM | 1M | 50K | – |
ARYA SCIENCES ACQU CORP IV | CL A | 2M | 134K | – |
ASTRIA THERAPEUTICS INC | COM | 9M | 976K | – |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 15M | 4M | – |
AVALO THERAPEUTICS INC | COM NEW | 561K | 45K | – |
AXSOME THERAPEUTICS INC | COM | 6M | 80K | – |
BEIGENE LTD | SPONSORED ADR | 16M | 110K | – |
BLACK DIAMOND THERAPEUTICS I | COM | 3M | 650K | – |
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 17M | – | – |
BRIDGEBIO PHARMA INC | COM | 3M | 100K | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 18M | 475K | – |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 10M | 1M | – |
CEREVEL THERAPEUTICS HLDNG I | COM | 20M | 500K | – |
CEREVEL THERAPEUTICS HLDNG I | COM | 10M | 250K | – |
COHERUS BIOSCIENCES INC | NOTE 1.500% 4/1 | 9M | – | – |
COMPASS PATHWAYS PLC | SPONSORED ADS | 3M | 501K | – |
CONTEXT THERAPEUTICS INC | COM | 3M | 2M | – |
CRINETICS PHARMACEUTICALS IN | COM | 23M | 515K | – |
CULLINAN THERAPEUTICS INC | COM | 5M | 264K | – |
DYNE THERAPEUTICS INC | COM | 4M | 100K | – |
ELEVATION ONCOLOGY INC | COM | 4M | 1M | – |
ELIEM THERAPEUTICS INC | COM | 12M | 2M | – |
ERASCA INC | COM | 6M | 2M | – |
ESTABLISHMENT LABS HLDGS INC | COM | 10M | 223K | – |
FULCRUM THERAPEUTICS INC | COM | 2M | 250K | – |
GENELUX CORPORATION | COM | 195K | 100K | – |
GERON CORP | COM | 6M | 2M | – |
HELIX ACQUISITION CORP II | CL A ORD SHS | 3M | 250K | – |
HILLEVAX INC | COM | 4M | 266K | – |
IMMATICS N.V | SHS | 3M | 300K | – |
IMMATICS N.V | *W EXP 07/01/202 | 485K | 187K | – |
IMMUNOVANT INC | COM | 9M | 346K | – |
IMMUNOVANT INC | COM | 1M | 54K | – |
INARI MED INC | COM | 10M | 200K | – |
INOZYME PHARMA INC | COM | 13M | 3M | – |
INSMED INC | COM PAR $.01 | 8M | 125K | – |
INSMED INC | COM PAR $.01 | 583K | 9K | – |
IOVANCE BIOTHERAPEUTICS INC | COM | 1M | 150K | – |
IOVANCE BIOTHERAPEUTICS INC | COM | 802 | 100 | – |
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 6M | – | – |
KEZAR LIFE SCIENCES INC | COM | 1M | 2M | – |
KURA ONCOLOGY INC | COM | 13M | 650K | – |
KYVERNA THERAPEUTICS INC | COM | 2M | 200K | – |
MADRIGAL PHARMACEUTICALS INC | COM | 31M | 110K | – |
MERSANA THERAPEUTICS INC | COM | 2M | 767K | – |
MERUS N V | COM | 7M | 125K | – |
MINERALYS THERAPEUTICS INC | COM | 4M | 328K | – |
MIRUM PHARMACEUTICALS INC | COM | 5M | 155K | – |
MORPHIC HLDG INC | COM | 9M | 251K | – |
NEUROBO PHARMACEUTICALS IN | COM | 432K | 89K | – |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 8M | 423K | – |
NEWAMSTERDAM PHARMA COMPANY | *W EXP 99/99/999 | 2M | 203K | – |
NEXTCURE INC | COM | 3M | 2M | – |
NKARTA INC | COM | 1M | 200K | – |
NURIX THERAPEUTICS INC | COM | 19M | 912K | – |
NUVALENT INC | COM | 15M | 200K | – |
OLEMA PHARMACEUTICALS INC | COM | 3M | 275K | – |
OMEROS CORP | NOTE 5.250% 2/1 | 8M | – | – |
PASSAGE BIO INC | COM | 210K | 264K | – |
PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | 4M | 350K | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 5M | 550K | – |
PROMIS NEUROSCIENCES INC | COM NEW | 399K | 266K | – |
PUMA BIOTECHNOLOGY INC | COM | 815K | 250K | – |
Q32 BIO INC | COM | 499K | 28K | – |
RAPT THERAPEUTICS INC | COM | 2M | 545K | – |
RAPT THERAPEUTICS INC | COM | 229K | 75K | – |
REZOLUTE INC | COM NEW | 8M | 2M | – |
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 5K | 75K | – |
ROIVANT SCIENCES LTD | SHS | 4M | 352K | – |
SANA BIOTECHNOLOGY INC | COM | 3M | 521K | – |
SAVARA INC | COM | 6M | 2M | – |
SPDR S&P 500 ETF TR | TR UNIT | 190M | 350K | – |
SPDR SER TR | S&P BIOTECH | 3M | 38K | – |
SPRINGWORKS THERAPEUTICS INC | COM | 3M | 70K | – |
SPYRE THERAPEUTICS INC | COM NEW | 12M | 513K | – |
TANGO THERAPEUTICS INC | COM | 1M | 150K | – |
TECTONIC THERAPEUTIC INC | COM | 961K | 58K | – |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 24M | 1M | – |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 19M | 1M | – |
TWIST BIOSCIENCE CORP | COM | 2M | 45K | – |
VAXCYTE INC | COM | 5M | 60K | – |
VAXCYTE INC | COM | 1M | 15K | – |
VERA THERAPEUTICS INC | CL A | 14M | 375K | – |
VERONA PHARMA PLC | SPONSORED ADS | 10M | 700K | – |
VIR BIOTECHNOLOGY INC | COM | 2M | 200K | – |
VIRIDIAN THERAPEUTICS INC | COM | 2M | 150K | – |
WAVE LIFE SCIENCES LTD | SHS | 2M | 375K | – |
XENON PHARMACEUTICALS INC | COM | 39M | 994K | – |
ZURA BIO LTD | CLASS A ORD SHS | 782K | 223K | – |
ZYMEWORKS INC | COM | 2M | 191K | – |